Medtronic
MDT
2,076 hedge funds and large institutions have $95.7B invested in Medtronic in 2024 Q1 according to their latest regulatory filings, with 175 funds opening new positions, 934 increasing their positions, 730 reducing their positions, and 146 closing their positions.
28% more repeat investments, than reductions
Existing positions increased: 934 | Existing positions reduced: 730
20% more first-time investments, than exits
New positions opened: 175 | Existing positions closed: 146
4% more capital invested
Capital invested by funds: $91.8B → $95.7B (+$3.91B)
0% more funds holding
Funds holding: 2,075 → 2,076 (+1)
1.05% less ownership
Funds ownership: 83.76% → 82.71% (-1.1%)
3% less funds holding in top 10
Funds holding in top 10: 32 → 31 (-1)
17% less call options, than puts
Call options by funds: $643M | Put options by funds: $778M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$533M |
| 2 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$271M |
| 3 |
National Pension Service
Jeonju-Si, Jeollabuk-Do,
South Korea
|
+$194M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$191M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$174M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.67B |
| 2 |
Wells Fargo
San Francisco,
California
|
-$440M |
| 3 |
BlackRock
New York
|
-$392M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$290M |
| 5 |
Millennium Management
New York
|
-$279M |
MDT Hedge Fund Activity: Q1 2024 in Review
2,076 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q1 2024, worth a combined $95.7B — up 4.3% from $91.8B a quarter earlier.
Buyers outnumbered sellers: 175 funds opened new MDT positions and 146 closed out — a net gain of 29 holders — while 934 added to existing stakes and 730 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $533M. The largest seller was Morgan Stanley, cutting an estimated $1.67B.
- 2,076 institutional investors held Medtronic (MDT) as of Q1 2024, up from 2,075 in Q4 2023.
- Funds reported $95.7B of Medtronic stock for Q1 2024, up 4.3% quarter-over-quarter.
- 175 funds opened new Medtronic positions in Q1 2024 and 146 closed out, a net change of +29 holders.
- The largest Medtronic buyer in Q1 2024 was JP Morgan Chase, an estimated $533M added.
- The largest Medtronic seller in Q1 2024 was Morgan Stanley, an estimated $1.67B sold.
Based on aggregated 13F filings for Q1 2024.